Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (8236)	1/7/1999 10:00:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Yes XOMA will do what they think is best for the company and for shareholders. They will also have all the facts. My concern is that circumstances can make anyone do something that is less attractive because there is no way to wait until things change to permit taking a more attractive alternative. If you need cash now you take the present value of a stream of projected sales that is probably conservative. We don't know how much GEN pays to take it back but it might not be a great deal. Think about it, XOMA got its' milestone payment for the completion of P II. Is there a big milestone payment for not going on with P III? But if PIII works and a product can be sold then XOMA gets to decide on a payment(s) or profit sharing.